Cutia Therapeutics (HKG:2487)
4.700
+0.330 (7.55%)
At close: Mar 6, 2026
Cutia Therapeutics Employees
Cutia Therapeutics had 298 employees as of June 30, 2025. The number of employees decreased by 35 or -10.51% since the number was reported on December 31, 2024.
Employees
298
Change
-35
Growth
-10.51%
Revenue / Employee
920.49K HKD
Profits / Employee
-1.74M HKD
Market Cap
1.71B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 298 | -35 | -10.51% |
| Dec 31, 2024 | 333 | 35 | 11.74% |
| Dec 31, 2023 | 298 | 123 | 70.29% |
| Dec 31, 2022 | 175 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1,629 |
| Frontage Holdings | 1,540 |
| Mabpharm | 383 |
| Zhaoke Ophthalmology | 270 |
| Clover Biopharmaceuticals | 243 |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 195 |
| Immunotech Biopharm | 173 |
| Antengene Corporation | 152 |